SCHEMBL13382002

SCHEMBL13382002

CN(C)C(=O)Sc1nsc(OCc2cccc(Cl)c2Cl)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.36
IDO1 P14902 2/20 0.35
KMT2A Q03164 3/20 0.35
ALDH1A1 P00352 1/20 0.35
PTPRC P08575 1/20 0.34
PTPRG P23470 1/20 0.34
MEN1 O00255 1/20 0.34
NPSR1 Q6W5P4 2/20 0.33
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
ALOX12 P18054 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
RXRA P19793 1/20 0.31
RXRB P28702 1/20 0.31
RXRG P48443 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13381968 0.91 MAOB (0.41) KMT2AALDH1A1MEN1MAOAMAOB
SCHEMBL13381997 0.88 NPSR1 (0.39) KMT2AALDH1A1NPSR1HTT
SCHEMBL13381999 0.83 MAOB (0.39) KMT2AALDH1A1MEN1MAOBMAPT
SCHEMBL13381993 0.83 ADORA3 (0.41) KMT2AALDH1A1MEN1MAPTADORA3
SCHEMBL13398887 0.82 RAB9A (0.31) ALDH1A1RAB9A
SCHEMBL13381967 0.82 MAOB (0.41) KMT2AALDH1A1MEN1MAOBL3MBTL1
SCHEMBL13381966 0.82 ALDH1A1 (0.39) IDO1KMT2AALDH1A1MEN1MAPT
SCHEMBL13381973 0.82 IDO1 (0.33) IDO1
SCHEMBL13381990 0.81 KMT2A (0.39) IDO1KMT2AMEN1NPSR1MAOB
SCHEMBL13381983 0.81 L3MBTL1 (0.40) KMT2AALDH1A1MEN1NPSR1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100081693-A1 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-01 US disclosed
US-20100081693-A1 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-01 US disclosed
WO-2008032858-A2 THIADIAZOLE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2008-03-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100081693-A1 THIADIAZOLE COMPOUND AND USE THEREOF NR2C2, NR4A3, NR0B2 CARM1 2867/4885IDO1 1716/4885KMT2A 4087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.